Cite
Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report
MLA
Vaibhav Kumar, et al. “Waldenström Macroglobulinemia with Secondary Pure Red Cell Aplasia in a Patient with Metastatic Castrate Resistant Prostate Cancer Receiving an Immune Checkpoint Inhibitor: A Case Report.” Journal of Medical Case Reports, vol. 17, no. 1, May 2023, pp. 1–5. EBSCOhost, https://doi.org/10.1186/s13256-023-03948-4.
APA
Vaibhav Kumar, Nathan D. Montgomery, Hendrik W. van Deventer, & Young E. Whang. (2023). Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report. Journal of Medical Case Reports, 17(1), 1–5. https://doi.org/10.1186/s13256-023-03948-4
Chicago
Vaibhav Kumar, Nathan D. Montgomery, Hendrik W. van Deventer, and Young E. Whang. 2023. “Waldenström Macroglobulinemia with Secondary Pure Red Cell Aplasia in a Patient with Metastatic Castrate Resistant Prostate Cancer Receiving an Immune Checkpoint Inhibitor: A Case Report.” Journal of Medical Case Reports 17 (1): 1–5. doi:10.1186/s13256-023-03948-4.